Monsanto Co. (MON) Director Charles S. Mcmillan Purchases 3,500 Shares
Monsanto Co. (NYSE:MON) Director Charles S. Mcmillan purchased 3,500 shares of Monsanto stock in a transaction that occurred on Monday, October 10th. The shares were bought at an average cost of $103.23 per share, for a total transaction of $361,305.00. Following the transaction, the director now directly owns 64,009 shares of the company’s stock, valued at $6,607,649.07. The transaction was disclosed in a filing with the SEC, which is available through the SEC website.
Monsanto Co. (NYSE:MON) opened at 102.32 on Thursday. The company has a market capitalization of $44.79 billion, a price-to-earnings ratio of 34.24 and a beta of 1.19. The stock has a 50 day moving average price of $104.66 and a 200 day moving average price of $101.70. Monsanto Co. has a 52-week low of $83.73 and a 52-week high of $114.26.
Monsanto (NYSE:MON) last issued its quarterly earnings data on Wednesday, October 5th. The company reported $0.07 EPS for the quarter, beating the consensus estimate of ($0.02) by $0.09. The firm earned $2.56 billion during the quarter, compared to the consensus estimate of $2.38 billion. Monsanto had a net margin of 9.89% and a return on equity of 46.07%. The company’s quarterly revenue was up 8.8% compared to the same quarter last year. During the same period in the prior year, the firm posted ($0.19) earnings per share. Equities research analysts forecast that Monsanto Co. will post $4.89 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, October 28th. Stockholders of record on Friday, October 7th will be paid a dividend of $0.54 per share. This represents a $2.16 annualized dividend and a dividend yield of 2.11%. The ex-dividend date of this dividend is Wednesday, October 5th. Monsanto’s dividend payout ratio (DPR) is 71.05%.
A number of equities research analysts recently issued reports on the company. Jefferies Group reissued a “buy” rating on shares of Monsanto in a research report on Tuesday, September 6th. Zacks Investment Research raised Monsanto from a “strong sell” rating to a “hold” rating in a research report on Tuesday, September 6th. Monness Crespi & Hardt raised Monsanto from a “neutral” rating to a “buy” rating and increased their price target for the stock from $106.93 to $130.00 in a research report on Monday, August 8th. TheStreet downgraded Monsanto from a “buy” rating to a “hold” rating in a research report on Monday, September 12th. Finally, BMO Capital Markets set a $128.00 price target on Monsanto and gave the stock a “buy” rating in a research report on Thursday, September 15th. Three research analysts have rated the stock with a sell rating, eight have issued a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the stock. The company has an average rating of “Buy” and an average target price of $114.65.
Several institutional investors have recently modified their holdings of the stock. WFG Advisors LP increased its position in shares of Monsanto by 18.6% in the second quarter. WFG Advisors LP now owns 1,009 shares of the company’s stock valued at $104,000 after buying an additional 158 shares during the period. Signaturefd LLC increased its position in shares of Monsanto by 62.1% in the second quarter. Signaturefd LLC now owns 1,083 shares of the company’s stock valued at $112,000 after buying an additional 415 shares during the period. Mycio Wealth Partners LLC increased its position in shares of Monsanto by 1.1% in the second quarter. Mycio Wealth Partners LLC now owns 1,094 shares of the company’s stock valued at $113,000 after buying an additional 12 shares during the period. Pinkerton Retirement Specialists LLC increased its position in shares of Monsanto by 1,179.1% in the second quarter. Pinkerton Retirement Specialists LLC now owns 1,100 shares of the company’s stock valued at $114,000 after buying an additional 1,014 shares during the period. Finally, Carnick & Kubik LLC purchased a new position in shares of Monsanto during the first quarter valued at approximately $130,000. 79.02% of the stock is owned by hedge funds and other institutional investors.
Monsanto Company Profile
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and precision agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Stock Ratings for Monsanto Co. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Co. and related stocks with our FREE daily email newsletter.